COVID-19 rapid guideline: managing COVID-19 [NG191],NICE (updated 13th April 2022)

This guideline covers the management of COVID-19 for children, young people and adults in all care settings. It brings together our existing recommendations on managing COVID-19, and new recommendations on therapeutics, so that healthcare staff and those planning and delivering services can find and use them more easily. We are continually monitoring the evidence and updating the guideline as new information emerges. 13 April 2022 We added a new recommendation on nirmatrelvir and ritonavir (Paxlovid) for people at high risk of progression to severe COVID-19. 30 March 2022 We updated existing recommendations on casirivimab and imdevimab - for people hospitalised because of COVID-19.
Source: Current Awareness Service for Health (CASH) - Category: Consumer Health News Source Type: news